+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Approval"

From
From
From
From
From
From
From
From
Pharmacovigilance - Global Strategic Business Report - Product Thumbnail Image

Pharmacovigilance - Global Strategic Business Report

  • Report
  • April 2025
  • 88 Pages
  • Global
From
Pharmacokinetics Services - Global Strategic Business Report - Product Thumbnail Image

Pharmacokinetics Services - Global Strategic Business Report

  • Report
  • April 2025
  • 89 Pages
  • Global
From
From
From
Biosimulation Technology - Global Strategic Business Report - Product Thumbnail Image

Biosimulation Technology - Global Strategic Business Report

  • Report
  • April 2025
  • 214 Pages
  • Global
From
From
Loading Indicator

The Drug Approval market is a key component of the Drug Discovery process. It involves the evaluation of a drug's safety and efficacy by regulatory authorities, such as the US Food and Drug Administration (FDA). This process is essential for the approval of a drug for commercial use. It involves the submission of a New Drug Application (NDA) to the FDA, which includes data from pre-clinical and clinical trials. The FDA then reviews the data and makes a decision on whether to approve the drug. The Drug Approval market is highly competitive, with many companies vying for approval of their drugs. Companies in the Drug Approval market include pharmaceutical companies such as Pfizer, Merck, and GlaxoSmithKline, as well as biotechnology companies such as Amgen and Genentech. Other companies involved in the market include contract research organizations (CROs) and clinical research organizations (CROs). Show Less Read more